[68Ga]RGD Versus [18F]FDG PET Imaging in Monitoring Treatment Response of a Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide

Autor: Jean-Noël Talbot, V. Nataf, Laura Rozenblum-Beddok, Aurélie Prignon, Fatiha Merabtene, Claire Provost

Publikováno v: Molecular Imaging and Biology. 21:297-305

The aim of this study was to evaluate positron emission tomography (PET) imaging with [68Ga]NODAGA-c(RGDfK) ([68Ga]RGD), in comparison with 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG), for early monitoring of the efficacy of an antiangiogenic agent as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ebd9572cd9fb4a1a3b3781c97d391d35
https://doi.org/10.1007/s11307-018-1224-9

TEP/TDM 68Ga-NODAGA-EXENDINE-4 dans la détection des insulinomes occultes : expérience de notre service de médecine nucléaire

Autor: V. Nataf, S. Gaujoux, O. Dubreuil, O. Bélissant, C. Aveline, T. Rusu, Françoise Montravers, Jean-Noël Talbot, M. Gotthardt, Y. Chevalme

Publikováno v: Médecine Nucléaire. 45:198

Introduction L’insulinome est la plus frequente des tumeurs neuroendocrines (TNE) fonctionnelles du pancreas, la plupart du temps benigne (sporadique ou au sein d’une neoplasie endocrinienne multiple ou NEM). Son traitement curatif est l’exeres

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fb5a7c55162adc06747d10c26f3a757d
https://doi.org/10.1016/j.mednuc.2021.06.052

Imagerie du cancer de la prostate oligométastatique, le point de vue du médecin nucléaire

Autor: C. Aveline, V. Nataf, Françoise Montravers, S. Balogova, T. Rusu, Jules Zhang-Yin, Jean-Noël Talbot, Mathieu Gauthé

Publikováno v: Médecine Nucléaire
Médecine Nucléaire, Elsevier/Masson, 2019, 43, pp.227-235. ⟨10.1016/j.mednuc.2019.01.036⟩

Resume De par son approche fonctionnelle et la bonne resolution des images obtenues, la TEP fusionnee a la TDM ou a l’IRM apparait comme la modalite d’imagerie actuellement la plus prometteuse pour deceler et denombrer les metastases des cancers.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f42f35beacde252a24c8fe8cefcae13
https://hal.archives-ouvertes.fr/hal-03486143/document

[PET/CT and biochemical recurrence of prostate adenocarcinoma: Added value of

Autor: M, Gauthé, O, Belissant, A, Girard, J, Zhang Yin, J, Ohnona, A-S, Cottereau, V, Nataf, S, Balogova, D, Pontvert, T, Lebret, B, Guillonneau, O, Cussenot, J-N, Talbot

Publikováno v: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 27(8-9)

Since April 201, we have introduced PET/CT using a ligand of prostate-specific membrane antigen labeled with gallium-68 (PSMA-11). We aimed to evaluate its positivity rate and impact in patients presenting biochemical recurrence of prostate cancer wh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dc411cdc2cfbfdda2ba110f89c398cde
https://pubmed.ncbi.nlm.nih.gov/28576423

32nd International Austrian Winter Symposium

Autor: W Langsteger, A Rezaee, W Loidl, HS Geinitz, F Fitz, M Steinmair, G Broinger, L Pallwien-Prettner, M Beheshti, L Imamovic, G Rendl, D Hackl, O Tsybrovsky, K Emmanuel, F Moinfar, C Pirich, A Bytyqi, G Karanikas, M Mayerhöfer, O Koperek, B Niederle, M Hartenbach, T Beyer, K Herrmann, J Czernin, I Rausch, P Rust, MD DiFranco, M Lassen, A Stadlbauer, ME Mayerhöfer, M Hacker, K Binzel, R Magnussen, W Wei, MU Knopp, DC Flanigan, C Kaeding, MV Knopp, A Leisser, M Nejabat, G Kramer, M Krainer, A Haug, Wencke Lehnert, Karl Schmidt, Sharok Kimiaei, Marcus Bronzel, Andreas Kluge, CL Wright, J Zhang, Evan Wuthrick, Piotr Maniawski, M Blaickner, E Rados, A Huber, M Dulovits, H Kulkarni, S Wiessalla, C Schuchardt, RP Baum, B Knäusl, D Georg, M Bauer, B Wulkersdorfer, W Wadsak, C Philippe, H Haslacher, M Zeitlinger, O Langer, M Feldmann, R Karch, MJ Koepp, M-C Asselin, E Pataraia, M Zeilinger, M Dumanic, F Pichler, J Pilz, M Mitterhauser, L Nics, B Steiner, A Traxl, Thomas Wanek, Kushtrim Kryeziu, Severin Mairinger, Johann Stanek, Walter Berger, Claudia Kuntner, Oliver Langer, S Mairinger, T Wanek, M Krohn, J Stanek, T Filip, M Sauberer, C Kuntner, J Pahnke, D Svatunek, C Denk, M Wilkovitsch, C Kuntner-Hannes, J Fröhlich, H Mikula, T Balber, J Singer, J Fazekas, C Rami-Mark, N Berroterán-Infante, E Jensen-Jarolim, H Viernstein, B Sohr, S Pfaff, E Halilbasic, M Visentin, B Stieger, M Trauner, P Lam, M Aistleitner, R Eichinger, C Artner, H Eidherr, C Vraka, H Kvaternik, R Müller, D Hausberger, C Zink, RM Aigner, U Cossío, M Asensio, A Montes, S Akhtar, Y te Welscher, R van Nostrum, V Gómez-Vallejo, J Llop, F VandeVyver, T Barclay, N Lippens, M Troch, L Hehenwarter, B Egger, J Holzmannhofer, M Rodrigues-Radischat, N Pötsch, D Wilhelm, M Weber, J Furtner, A Wöhrer, T Traub-Weidinger, T Cassou-Mounat, S Balogova, V Nataf, M Calzada, V Huchet, K Kerrou, J-Y Devaux, M Mohty, L Garderet, J-N Talbot, S Stanzel, G Pregartner, T Schwarz, V Bjelic-Radisic, B Liegl-Atzwanger, R Aigner, F Quehenberger, A Koljević Marković, Milica Janković, V Miler Jerković, M Paskaš, G Pupić, R Džodić, D Popović, MC Fornito, D Familiari, P Koranda, H Polzerová, I Metelková, L Henzlová, R Formánek, E Buriánková, M Kamínek, WH Thomson, C Lewis, J O’Brien, G James, A Notghi, H Huber, I Stelzmüller, R Wunn, M Mandl, F Fellner, B Lamprecht, M Gabriel, G Leonardi, J Hudzietzová, J Sabol, M Fülöp

Publikováno v: EJNMMI Research

Table of contents A1 68Ga-PSMA PET/CT in staging and restaging of Prostate Cancer Patients: comparative study with 18F-Choline PET/CT W Langsteger, A Rezaee, W Loidl, HS Geinitz, F Fitz, M Steinmair, G Broinger, L Pallwien-Prettner, M Beheshti A2 F18

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c57c5458ca3ce749c88583da832cc19d
https://doi.org/10.1186/s13550-016-0168-9